SNY
Sanofi·NASDAQ
--
--(--)
--
--(--)
4.94 / 10
Netural
Analyst sentiment is neutral with a 1 Strong Buy, 5 Buy, and 8 Hold ratings, averaging to a Moderate Buy but with low conviction. Fund-flow analysis shows a good score of 7.8/10, yet all flow categories (block, small, medium, large, extra-large) trend negatively. This mix suggests institutional caution despite positive money flow metrics.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-16
InstitutionUBS
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for SNY?
- SNY holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.94/10 (Netural).
